{"name":"Midas Pharma GmbH","slug":"midas-pharma-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ramipril, Amlodipine and Atorvastatin","genericName":"Ramipril, Amlodipine and Atorvastatin","slug":"ramipril-amlodipine-and-atorvastatin","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Ramipril, Amlodipine and Atorvastatin","genericName":"Ramipril, Amlodipine and Atorvastatin","slug":"ramipril-amlodipine-and-atorvastatin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQQzRRaWxaX0Y4TVVjdVdRREgyYjFaVDZRMjJBak1mSGxUdC1WOWV5b0VGUW90RGcyQ05fcXh4RkNyRzdvSmJQMy1fc1M5UmNPWEFGZDlkalJXRmEyYTlvTlpuMWd6RTF0d1JPZzJHY0lZWkE5MjZ5MVpTbzRVOHJnczBR?oc=5","date":"2026-01-22","type":"regulatory","source":"JD Supra","summary":"How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline - Updated January 22, 2026 - JD Supra","headline":"How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline - Updated January 22, 2026","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxPcUJ1QV9tZlZDUDJIU0JsNXUzanZvTDhLWjhOQS1LTDVQYjRFY0s0ekJLVUNwM1VOSE5qZ29NSTY5WndGTWlOVWFqQVl0b3dxVlpXb21OcWtHOHFVX0JlbUduY3hxRnhpNXFLSkFJbHRpelFFdlEzZHZhbmdhSGg3aEFENmJacl9lRUlna3RVajlXdjljVm44SC1oTDZFeE5FczF5UlllQUVvNkdObHBYM0VsLWJ4U2lpaUc0ZjU2V2dKY0Y1bDdXX1RZWnRxVHVGeEhEcENVb09UNm83SGVVMUEzanJKcUd4b1NuYmR6MjNkVngyOXB4NUhhYXJUcEZIbWc?oc=5","date":"2025-05-28","type":"pipeline","source":"BioSpace","summary":"Pharmaceutical Intermediates Industry Report 2025: Market to worth $82.70 Billion by 2032 - Driven by Surge in Global Pharma Expenditure - BioSpace","headline":"Pharmaceutical Intermediates Industry Report 2025: Market to worth $82.70 Billion by 2032 - Driven by Surge in Global Ph","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQMHlHOHo4Vzc4cm5sV01mNE03czgzcGdJZURlMmZ5ekhteGRubDVkWVd0dExhSS1hUXJaSTUxY1pMSmJMWW11cXRBVTFEeDBtX05adTZORmhVSURjUk9CM0V0SkdnLXVRbjVkZG5VTWJfZ0V5M3llcndYQWM0RjlDSGxyVksxSkYxTEZacDJR?oc=5","date":"2025-02-16","type":"pipeline","source":"Future Market Insights","summary":"China Pharmaceutical Intermediate Market Size 2025-2035 - Future Market Insights","headline":"China Pharmaceutical Intermediate Market Size 2025-2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgJBVV95cUxOWnZOak5CQU5mc1hwRFBIVkVjakptOW5JNjZEaG0zVDg0NDlNQXBoYzF4WWxtWFM4Sm03YzV4Qjc0YnlKZGtJT2F3S2JEV1NzbVdRZVpGdGRpZHJaVVBmSE5UZWI5bmgzaGFaSkk1YVJGTzVGdXM5dktDYXBQUmZXYmtZTENRd1NIcWhuTTRsdm1kZk16LVprOGxYVEN2Z0hRNkFUQndDNEdXXzJ5M1VYZlB3bktFZi1KaFRXa3ZRck9ZTUpiZzBON2tScE12Rk9WTkZXdTlGR2hQbVc5cld6ZUZ4SWU3QVZpWlZhVmlWUUg2V2VaN1lTMkJQX3JxU0tmWFgwUWs2X01pSUZEY2NmMHA5MzN1WVhIRDZTekM3UGlDeVV1NW9QelI0bzlmTlZuT2E3ek5BdXlwOEhCUXg4SWxn?oc=5","date":"2025-01-14","type":"pipeline","source":"PR Newswire","summary":"Anticoagulant Reversal Drugs Market to Grow by USD 1.27 Billion from 2025-2029, Driven by Rising Coagulation Disorders and AI-Redefined Market Landscape - Technavio - PR Newswire","headline":"Anticoagulant Reversal Drugs Market to Grow by USD 1.27 Billion from 2025-2029, Driven by Rising Coagulation Disorders a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNRlA3MldGV1BTUTgzeWhyZ0owcGtYeDFRZWprSjZfLVJMZGlOTE9qMU4tNWo5N3ZEajlEVUlIT1M5TlN0b29wVjNUdTM3c2Vpem1aeTFjNS1YVUVEd0g1b0NyalltUGZnbHkxYlV4MC1OWmpFYVRjZExDT3RVOHZOTmNB?oc=5","date":"2025-01-14","type":"regulatory","source":"JD Supra","summary":"How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline - Updated January 13, 2025 - JD Supra","headline":"How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline - Updated January 13, 2025","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPbUpSRWdaT1Z1XzRsMVFMNE1IejBVUkpuQldidXlldVRHZ3NGeklGdTNucU5NSXRWZG5mOTdaYnR2alhPQlZadHVLV2VXVzNETXVlNTV0eFZ4QWQ5MXR3OUtreUltNUpVRWhwXzJZd3RxRnFsS2RKTTBjSkVkVURTRlRKc3RmUE1ycFdyUXE0eWFMWlk?oc=5","date":"2024-10-25","type":"pipeline","source":"kingsresearch.com","summary":"Pharmaceutical Intermediates: Top 10 Companies to Watch - kingsresearch.com","headline":"Pharmaceutical Intermediates: Top 10 Companies to Watch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPNmJOVEduZmRqSkFzZHo5clBQMkJ4a1pWNTZIMGJyWlYxeGZwRGNJU0hzTC1KU2RBMjFzTGJnU3liNU9hZVM4Zm9ibkRtVWN0VkIxOWlhQnBzZjRJV3ctWXdpUl9MY3Q0UU84Z05GRUQtbkxFU3VGTTZobV9mVHdOVVlwTGhxMGN2UnNwUVlTS29HYnJoNFg0bExuNnhmV0pXNkw3WUxnUUJmTmZDbm8tVXBn?oc=5","date":"2024-07-26","type":"regulatory","source":"European Medicines Agency (EMA)","summary":"Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 July 2024 - European Medicines Agency (EMA)","headline":"Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 July 2024 - European Medicines A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNUDZZQVZXRFB6dkJUelBIei1YNEpMS2hBVDJGUV9fWGxoUEt0VEFudzJicVVZUnpNbzk1X1FBdW1qZnUxbUdKaGdQZWZyaEY5bHJPMThCdnlXR2l4ejFDRjdaYjdrak1ZWm9uWHVEMWNnVUVVel85YUNoM0JNWmdBWnJWWEpXcXFLQ2hLTEduOEd4Y3pWS1ZrbGF1MnVuOWNKSFRzbjZUZldBaUNpWnZTZG1VZUdFUU1aNk9jNHN6dkI2M3JoYmV1UHlpbkQta3FFOVY5M09UVXdoSmZadjdpbw?oc=5","date":"2023-11-10","type":"pipeline","source":"PharmiWeb.com","summary":"Pharmaceutical Intermediates Market is set to expand with a 4.3% CAGR by 2030, focusing on ensuring - PharmiWeb.com","headline":"Pharmaceutical Intermediates Market is set to expand with a 4.3% CAGR by 2030, focusing on ensuring","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQeHVISjVBd1pWaFZkN2ZTd3o0OFJ0RWROVGlnX282b19iYVJNMEZBSVl2ZnRYTjhIOFc5LXhYdW1VYy1XdVBxUWVRcW1BVmRGc2dMbzhrX1VLSTlWLWd6QTdaaEstbGhsc0s4S0Z0dHFkX3BUcHFqbEdINE5jdVhobVBFbkJfdEU?oc=5","date":"2023-08-24","type":"pipeline","source":"Yahoo Finance","summary":"Beta Blockers Global Market Report 2023 - Yahoo Finance","headline":"Beta Blockers Global Market Report 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFAxRklOb3RlamFIMVl0Z2g0OTlrcXIxSlNzRld0azN2bE1wSFpuWXBUU3dvM21lYnpuems5VGtDYlVUOU1aZDdzUFMyMnR0NzZWWWh6MjlMZFk0TUxhTjNPUnhUTHh1NVhtUVpPN1p3?oc=5","date":"2022-12-13","type":"pipeline","source":"Spherical Insights","summary":"Cyclodextrin Market Includes Latest Trends, Share, and Forecast 2030 - Spherical Insights","headline":"Cyclodextrin Market Includes Latest Trends, Share, and Forecast 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNVlZSR29qVzFCaVJMZ0xhLThtVFBZSDRUcmJzMjBtam1LZ1dBMHpVa09EbnlzUmlBeV9mZmhvZnVMLTh2X0huUEFCdkpOcnBkd21WNk5vTlFhSTZEQk1SN1dHemtxZzhZV1M1M1lDanZGUzRQZkRaUzUzU2VSbnpTLXI1OA?oc=5","date":"2021-01-11","type":"regulatory","source":"Generics and Biosimilars Initiative","summary":"Biosimilars approved in Europe - Generics and Biosimilars Initiative","headline":"Biosimilars approved in Europe","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9HWjczd3lFRUVUVkNPZTlQR21teFFhUlZOdlNrWnZid1Rhcl9ibUV6aGxzM19NMDhqYTZDZFFlc0t3N21vczl2cFhTTzRLa2FOM1U0OU1Wckd4UzlxTVpITk1JTXZ2X2Y5R2c?oc=5","date":"2015-05-15","type":"pipeline","source":"Allied Market Research","summary":"Salicylic Acid Market Size, Share | Industry Forecast, 2030 - Allied Market Research","headline":"Salicylic Acid Market Size, Share | Industry Forecast, 2030","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}